These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17085644)

  • 41. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital.
    Patel UA; Thakkar KH; Holloway N
    Laryngoscope; 2008 Mar; 118(3):428-32. PubMed ID: 18043491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer.
    Paz-Elizur T; Ben-Yosef R; Elinger D; Vexler A; Krupsky M; Berrebi A; Shani A; Schechtman E; Freedman L; Livneh Z
    Cancer Res; 2006 Dec; 66(24):11683-9. PubMed ID: 17178863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
    Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
    Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
    Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
    Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck.
    Morgan JE; Breau RL; Suen JY; Hanna EY
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):10-4. PubMed ID: 17224515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. National Cancer Database report on cancer of the head and neck: 10-year update.
    Cooper JS; Porter K; Mallin K; Hoffman HT; Weber RS; Ang KK; Gay EG; Langer CJ
    Head Neck; 2009 Jun; 31(6):748-58. PubMed ID: 19189340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Taguchi T
    Acta Otolaryngol; 2007 Oct; 127(10):1099-104. PubMed ID: 17851890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity.
    Wu CH; Hsieh SC; Li KJ; Lu MC; Yu CL
    Lupus; 2007; 16(4):265-72. PubMed ID: 17439933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
    Nakamura K; Tahara M; Kiyota N; Hayashi R; Akimoto T; Fukuda H; Fujii M; Boku N
    Jpn J Clin Oncol; 2009 Jul; 39(7):460-3. PubMed ID: 19429640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients.
    Levy T; Agoulnik I; Atkinson EN; Tong XW; Gause HM; Hasenburg A; Runnebaum IB; Stickeler E; Möbus VJ; Kaplan AL; Kieback DG
    Anticancer Res; 1998; 18(3A):1345-9. PubMed ID: 9673338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
    J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer survival is associated with telomere length in peripheral blood cells.
    Svenson U; Nordfjäll K; Stegmayr B; Manjer J; Nilsson P; Tavelin B; Henriksson R; Lenner P; Roos G
    Cancer Res; 2008 May; 68(10):3618-23. PubMed ID: 18483243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
    Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer.
    Patel UA; Patadia MO; Holloway N; Rosen F
    Laryngoscope; 2009 Mar; 119(3):528-33. PubMed ID: 19160390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
    Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paternal age is positively linked to telomere length of children.
    Unryn BM; Cook LS; Riabowol KT
    Aging Cell; 2005 Apr; 4(2):97-101. PubMed ID: 15771613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.